Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
West Nile virus (WNV) is a mosquito-borne flavivirus that is endemic in Africa, the Middle East, Europe and the United States. There is currently no antiviral treatment or human vaccine available to treat or prevent WNV infection. DNA plasmid-based vaccines represent a new approach for controlling i...
Main Authors: | Marina De Filette, Silke Soehle, Sebastian Ulbert, Justin Richner, Michael S Diamond, Alessandro Sinigaglia, Luisa Barzon, Stefan Roels, Julianna Lisziewicz, Orsolya Lorincz, Niek N Sanders |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3913677?pdf=render |
Similar Items
-
T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice.
by: Marina De Filette, et al.
Published: (2014-01-01) -
Recent progress in West Nile virus diagnosis and vaccination
by: De Filette Marina, et al.
Published: (2012-03-01) -
Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge
by: The Staff
Published: (2014-01-01) -
Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge.
Published: (2014-01-01) -
Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
by: Babs E Verstrepen, et al.
Published: (2014-01-01)